Platelet-derived growth factor signaling in human malignancies

Chinese Journal of Cancer

Volumn 30, Issue 9, 2011, Pages 581-584

  Liu, Kun Wei ^a,b,c   Hu, Bo ^a,b   Cheng, Shi Yuan ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c BURNHAM INSTITUTE   (United States)

Author keywords

Cancer; Drug resistance; Platelet derived growth factor; Tumor progression

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOCRINE EFFECT; BREAST CANCER; CARCINOGENESIS; DRUG EFFECT; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST; FIBROSARCOMA; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METASTASIS; NONHUMAN; PARACRINE SIGNALING; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOFT TISSUE SARCOMA; STROMA CELL; TUMOR GROWTH; TUMOR PROMOTION;

ANIMALS; AUTOCRINE COMMUNICATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; PARACRINE COMMUNICATION; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 80053077850     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.011.10300     Document Type: Editorial

References (45)

1. Ross R, Glomset J, Kariya B, et al. A platelet-de pendent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro [J]. Proc Natl Acad Sci U S A, 1974,71 (4):1207-1210.
2. Kohler N, Lipton A. Platelets as a source of fibroblast growth-promoting activity [J]. Exp Cell Res, 1974,87(2):297-301.
3. Ross R, Vogel A. The platelet-derived growth factor [J]. Cell, 1978,14(2):203-210.
4. Waterfield MD, Scrace GT, Whittle N, et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus [J]. Nature, 1983,304 (5921):35-39.
5. Doolittle RF, Hunkapiller MW, Hood LE, et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor [J]. Science, 1983, 221 (4607):275-277.
6. Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops [J]. Cancer Res, 1992,52(11):3213-3219.
7. Smits A, Funa K, Vassbotn FS, et al. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin [J]. Am J Pathol, 1992,140(3):639-648.
8. Seymour L, Dajee D, Bezwoda WR. Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer [J]. Breast Cancer Res Treat, 1993,26(3):247-252.
9. Jechlinger M, Grunert S, Tamir IH, et al. Expression profiling of epithelial plasticity in tumor progression [J]. Oncogene, 2003,22(46):7155-7169.
10. Jechlinger M, Sommer A, Moriggl R, et al. Autocrine PDGFR signaling promotes mammary cancer metastasis [J]. J Clin Invest, 2006,116(6):1561-1570.
11. Ostman A. PDGF receptors-m ediators of autocrine tumor growth and regulators of tumor vasculature and stroma [J]. Cytokine Growth Factor Rev, 2004,15(4):275-286.
12. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine [J]. Genes Dev, 2008,22(10):1276-1312.
13. Nister M, Libermann TA, Betsholtz C, et al. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines [J]. Cancer Res, 1988,48(14):3910-3918.
14. Hermanson M, Funa K, Koopmann J, et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas [J]. Cancer Res, 1996,56(1):164-171.
15. Liu KW, Feng H, Bachoo R, et al. SHP-2/ PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans [J]. J Clin Invest, 2011,121(3):905-917.
16. Clarke ID, Dirks PB. A human brain tumor-derived PDGFR-alpha deletion mutant is transforming [J]. Oncogene, 2003,22 (5):722-733.
17. Ozawa T, Brennan CW, Wang L, et al. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas [J]. Genes Dev, 2010,24 (19):2205-2218.
18. Liu KW, Hu B, Cheng SY. Platelet-derived growth factor receptor alpha in gliomas: a bad seed [J]. Chin J Cancer, 2011, 30(9): 590-602.
19. Pech M, Gazit A, Arnstein P, et al. Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene [J]. Proc Natl Acad Sci U S A, 1989,86(8):2693-2697.
20. Wang J, Coltrera MD, Gown AM. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study [J]. Cancer Res, 1994,54(2):560-564.
21. Tamborini E, Bonadiman L, Greco A, et al. Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma [J]. Clin Cancer Res, 2004,10(3):938-943.
22. Wang Y, Zhou BP. Epithelial-mesenchymal transition in breast cancer progression and metastasis [J]. Chin J Cancer, 2011, 30 (9): 603-611.
23. Bruna A, Darken RS, Rojo F, et al. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene [J]. Cancer Cell, 2007,11(2):147-160.
24. Simon MP, Pedeutour F, Sirvent N, et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma [J]. Nat Genet, 1997,15(1):95-98.
25. Greco A, Fusetti L, Villa R, et al. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans [J]. Oncogene, 1998,17(10): 1313-1319.
26. Shimizu A, O'Brien KP, Sjoblom T, et al. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-B B [J]. Cancer Res, 1999,59(15):3719-3723.
27. Baxter EJ, Hochhaus A, Bolufer P, et al. The t (4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA [J]. Hum Mol Genet, 2002,11(12):1391-1397.
28. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J]. N Engl J Med, 2003,348(13):1201-1214.
29. Golub TR, Barker GF, Lovett M, et al. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t (5;12) chromosomal translocation [J]. Cell, 1994,77(2):307-316.
30. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors [J]. Science, 2003,299(5607):708-710.
31. Hirota S, Ohashi A, Nishida T, et al. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors [J]. Gastroenterology, 2003,125 (3):660-667.
32. Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors [J]. J Clin Invest, 2003,112(8):1142-1151.
33. Guo P, Hu B, Gu W, et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment [J]. Am J Pathol, 2003,162(4): 1083-1093.
34. Furuhashi M, Sjoblom T, Abramsson A, et al. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate [J]. Cancer Res, 2004,64 (8): 2725-2733.
35. Hermansson M, Nister M, Betsholtz C, et al. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation [J]. Proc Natl Acad Sci U S A, 1988,85(20):7748-7752.
36. Hwang RF, Yokoi K, Bucana CD, et al. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model [J]. Clin Cancer Res, 2003,9(17):6534-6544.
37. Apte SM, Fan D, Killion JJ, et al. Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma [J]. Clin Cancer Res, 2004,10(3):897-908.
38. Uehara H, Kim SJ, Karashima T, et al. Effects of blocking platelet-derived growth factor-re ceptor signaling in a mouse model of experimental prostate cancer bone metastases [J]. J Natl Cancer Inst, 2003,95(6):458-470.
39. Liu Q, Jernigan D, Zhang Y, et al. Implication of platelet-derived growth factor alpha-re ceptor in prostate cancer skeletal metastasis [J]. Chin J Cancer, 2011, 30(9): 612-619.
40. Skobe M, Fusenig NE. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation [J]. Proc Natl Acad Sci U S A, 1998,95(3):1050-1055.
41. Dong J, Grunstein J, Tejada M, et al. VEGF-nu ll cells require PDGFR alpha signaling-m ediated stromal fibroblast recruitment for tumorigenesis [J]. EMBO J, 2004,23(14):2800-2810.
42. Pietras K, Pahler J, Bergers G, et al. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting [J]. PLoS Med, 2008,5(1):e19.
43. Heuchel R, Berg A, Tallquist M, et al. Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3' kinase signaling [J]. Proc Natl Acad Sci U S A, 1999,96(20):11410-11415.
44. Pietras K, Ostman A, Sjoquist M, et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors [J]. Cancer Res, 2001,61(7):2929-2934.
45. Pietras K, Stumm M, Hubert M, et al. STI571 enhances the therapeutic index of epothilone B by a tumor-se lective increase of drug uptake [J]. Clin Cancer Res, 2003,9(10 Pt 1):3779-3787.